PKM and psoriasis: In summary, our findings suggest that intraperitoneal administration of HCA ameliorates IMQ-induced psoriasis-like symptoms in mice by reducing Th17 immune responses, specifically by inhibiting PKM2-STAT3 signaling in Th17 cells and keratinocytes.